Post-Operative Pain - Pipeline Review, H2 2017

Published: Jul, 2017 | Pages: 191 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Pipeline Review, H2 2017, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape.

Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation, age, level of fear or anxiety, surgical procedure, personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Post-Operative Pain - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 1, 10, 16, 8, 14, 3 and 2 respectively. Similarly, the Universities portfolio in Phase III and Preclinical stages comprises 1 and 1 molecules, respectively.

Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Operative Pain (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Post-Operative Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Post-Operative Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Post-Operative Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Post-Operative Pain (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Post-Operative Pain (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Post-Operative Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

 Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Post-Operative Pain - Overview 8
Post-Operative Pain - Therapeutics Development 9
Pipeline Overview 9
Pipeline by Companies 10
Pipeline by Universities/Institutes 14
Products under Development by Companies 15
Products under Development by Universities/Institutes 18
Post-Operative Pain - Therapeutics Assessment 19
Assessment by Target 19
Assessment by Mechanism of Action 22
Assessment by Route of Administration 25
Assessment by Molecule Type 27
Post-Operative Pain - Companies Involved in Therapeutics Development 29
Abide Therapeutics Inc 29
AcelRx Pharmaceuticals Inc 29
Adynxx Inc 30
AngioChem Inc 30
Aoxing Pharmaceutical Company Inc 31
Camurus AB 31
Cara Therapeutics Inc 32
Center Laboratories Inc 32
Colby Pharmaceutical Company 33
Cytogel Pharma LLC 33
Dompe Farmaceutici SpA 34
DURECT Corp 34
Eupraxia Pharmaceuticals Inc 35
EyeGate Pharmaceuticals Inc 35
Fujimoto Pharmaceutical Corp 36
GW Pharmaceuticals Plc 36
Heron Therapeutics Inc 37
Immupharma Plc 37
Innocoll AG 38
Insys Therapeutics Inc 38
Lipocure Ltd 39
Liquidia Technologies Inc 39
Medtronic Plc 40
Mundipharma International Ltd 40
Novartis AG 41
Orion Oyj 41
Pacira Pharmaceuticals Inc 42
PainReform Ltd 42
PhytoHealth Corp 43
PixarBio Corp 43
Proteus SA 44
Recro Pharma Inc 44
Relmada Therapeutics Inc 45
Serina Therapeutics Inc 45
SteadyMed Therapeutics Inc 46
Teikoku Pharma USA Inc 46
The Medicines Company 47
Trevena Inc 47
Xigen SA 48
Post-Operative Pain - Drug Profiles 49
(bupivacaine hydrochloride + meloxicam) ER - Drug Profile 49
(buprenorphine hydrochloride + granisetron hydrochloride) ER - Drug Profile 52
A-100 - Drug Profile 53
ABD-1970 - Drug Profile 54
ANG-2002 - Drug Profile 55
ARX-04 - Drug Profile 56
AYX-1 - Drug Profile 64
brimapitide - Drug Profile 67
bupivacaine hydrochloride - Drug Profile 71
bupivacaine hydrochloride - Drug Profile 72
bupivacaine hydrochloride - Drug Profile 73
bupivacaine hydrochloride - Drug Profile 74
bupivacaine hydrochloride SR - Drug Profile 77
bupivacaine hydrochloride SR - Drug Profile 82
buprenorphine hydrochloride - Drug Profile 83
CAM-2048 - Drug Profile 84
carbamazepine - Drug Profile 85
CPC-111 - Drug Profile 86
CPC-123 - Drug Profile 87
CT-044 - Drug Profile 88
Cyt-1010 - Drug Profile 89
dexamethasone acetate - Drug Profile 91
dexmedetomidine hydrochloride - Drug Profile 97
DF-2755A - Drug Profile 98
difelikefalin - Drug Profile 99
Drug to Agonize MOR1 for Pain - Drug Profile 109
ECP-1014 - Drug Profile 110
fadolmidine hydrochloride - Drug Profile 112
fentanyl - Drug Profile 113
gonyautoxin - Drug Profile 114
HTX-009 - Drug Profile 115
HYLP-002 - Drug Profile 116
IPP-102199 - Drug Profile 117
ketorolac tromethamine - Drug Profile 118
lacosamide - Drug Profile 119
levorphanol tartrate ER - Drug Profile 120
MDT-10013 - Drug Profile 122
meloxicam - Drug Profile 123
meloxicam ER - Drug Profile 128
MR-309 - Drug Profile 129
nabiximols - Drug Profile 131
nalbuphine hydrochloride - Drug Profile 138
neosaxitoxin - Drug Profile 139
oliceridine - Drug Profile 141
PMZ-2010 - Drug Profile 148
RBM-004 - Drug Profile 150
ropivacaine - Drug Profile 151
ropivacaine ER - Drug Profile 152
SAF-312 - Drug Profile 153
SER-226 - Drug Profile 154
Small Molecule for Post-Operative Pain - Drug Profile 155
Small Molecules to Inhibit COX for Postoperative Acute Pain - Drug Profile 156
sufentanil citrate - Drug Profile 157
tilidine hydrochloride - Drug Profile 165
tramadol hydrochloride - Drug Profile 166
URB-937 - Drug Profile 167
VVZ-149 - Drug Profile 168
XEN-105 - Drug Profile 170
Post-Operative Pain - Dormant Projects 171
Post-Operative Pain - Discontinued Products 174
Post-Operative Pain - Product Development Milestones 175
Featured News & Press Releases 175
Appendix 186
Methodology 186
Coverage 186
Secondary Research 186
Primary Research 186
Expert Panel Validation 186
Contact Us 186
Disclaimer 187

List of Tables

Number of Products under Development for Post-Operative Pain, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Post-Operative Pain - Pipeline by Abide Therapeutics Inc, H2 2017
Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals Inc, H2 2017
Post-Operative Pain - Pipeline by Adynxx Inc, H2 2017
Post-Operative Pain - Pipeline by AngioChem Inc, H2 2017
Post-Operative Pain - Pipeline by Aoxing Pharmaceutical Company Inc, H2 2017
Post-Operative Pain - Pipeline by Camurus AB, H2 2017
Post-Operative Pain - Pipeline by Cara Therapeutics Inc, H2 2017
Post-Operative Pain - Pipeline by Center Laboratories Inc, H2 2017
Post-Operative Pain - Pipeline by Colby Pharmaceutical Company, H2 2017
Post-Operative Pain - Pipeline by Cytogel Pharma LLC, H2 2017
Post-Operative Pain - Pipeline by Dompe Farmaceutici SpA, H2 2017
Post-Operative Pain - Pipeline by DURECT Corp, H2 2017
Post-Operative Pain - Pipeline by Eupraxia Pharmaceuticals Inc, H2 2017
Post-Operative Pain - Pipeline by EyeGate Pharmaceuticals Inc, H2 2017
Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corp, H2 2017
Post-Operative Pain - Pipeline by GW Pharmaceuticals Plc, H2 2017
Post-Operative Pain - Pipeline by Heron Therapeutics Inc, H2 2017
Post-Operative Pain - Pipeline by Immupharma Plc, H2 2017
Post-Operative Pain - Pipeline by Innocoll AG, H2 2017
Post-Operative Pain - Pipeline by Insys Therapeutics Inc, H2 2017
Post-Operative Pain - Pipeline by Lipocure Ltd, H2 2017
Post-Operative Pain - Pipeline by Liquidia Technologies Inc, H2 2017
Post-Operative Pain - Pipeline by Medtronic Plc, H2 2017
Post-Operative Pain - Pipeline by Mundipharma International Ltd, H2 2017
Post-Operative Pain - Pipeline by Novartis AG, H2 2017
Post-Operative Pain - Pipeline by Orion Oyj, H2 2017
Post-Operative Pain - Pipeline by Pacira Pharmaceuticals Inc, H2 2017
Post-Operative Pain - Pipeline by PainReform Ltd, H2 2017
Post-Operative Pain - Pipeline by PhytoHealth Corp, H2 2017
Post-Operative Pain - Pipeline by PixarBio Corp, H2 2017
Post-Operative Pain - Pipeline by Proteus SA, H2 2017
Post-Operative Pain - Pipeline by Recro Pharma Inc, H2 2017
Post-Operative Pain - Pipeline by Relmada Therapeutics Inc, H2 2017
Post-Operative Pain - Pipeline by Serina Therapeutics Inc, H2 2017
Post-Operative Pain - Pipeline by SteadyMed Therapeutics Inc, H2 2017
Post-Operative Pain - Pipeline by Teikoku Pharma USA Inc, H2 2017
Post-Operative Pain - Pipeline by The Medicines Company, H2 2017
Post-Operative Pain - Pipeline by Trevena Inc, H2 2017
Post-Operative Pain - Pipeline by Xigen SA, H2 2017
Post-Operative Pain - Dormant Projects, H2 2017
Post-Operative Pain - Dormant Projects, H2 2017 (Contd..1), H2 2017
Post-Operative Pain - Dormant Projects, H2 2017 (Contd..2), H2 2017
Post-Operative Pain - Discontinued Products, H2 2017